By Tobore Ovuorie
ANALYSIS of data from 38 African countries indicates very few, if any, are on track to reach the UNAIDS targets for HIV testing and condom use by the year 2030.
This was one of the major highlights in HIV prevention research announced Tuesday at the 4
th HIV Research for Prevention Conference (HIVR4P), convened by the International AIDS Society (IAS). The annual gathering of researchers, thinktanks, amongst others in the HIV field holds virtually this year, due to the COVID-19 epidemic.
Based on 114 nationally-representative datasets representing more than 1.4 million sexually active people, the study presented by Phuong Nguyen of St. Luke’s International University revealed that overall, the probabilities of reaching the 2030 targets were very low for both HIV testing at 0 percent to 28.5 percent and condom use with 0 percent to 12.1 percent.
Friday, 29 January 2021, 5:47 am
Wednesday, 27 January, 2021 (Geneva, Switzerland) Researchers, advocates and policy makers
advancing global efforts to end HIV/AIDS will be honoured
with awards at HIVR4P // Virtual – the HIV
Research for Prevention
Conference, to be held 27 & 28 January and 3 & 4
February 2021. Organized by IAS – the International
AIDS Society – HIVR4P is the only global scientific
conference dedicated exclusively to biomedical HIV
prevention research.
“The awards programme at HIVR4P
// Virtual recognizes outstanding HIV prevention research,
compelling advocacy to curtail the epidemic, and exceptional
commitments to safeguarding the human rights of people
impacted by HIV,” said IAS President Adeeba Kamarulzaman
of the University of Malaya. “This conference, and these
Scientists find breakthrough in AMP study for HIV prevention
Top Story
January 27, 2021
LAHORE: The global scientists have found encouraging results of latest Antibody Mediated Prevention (AMP) studies for HIV prevention, which show promise to prevent some HIV infections. The International AIDS Society (IAS) welcomed new results from two proof-of-concept AMP studies (HVTN 704/HPTN 085 and HVTN 703/HPTN 081) demonstrating that infusions of the broadly neutralising monoclonal HIV antibody (bNAb) VRC01 can prevent some HIV infections. The results of the AMP study, which were announced on Tuesday ahead of the opening of the 4th HIV Research for Prevention Conference (HIVR4P/Virtual), include data from more than 4,600 participants in two studies that enrolled HIV-negative men and transgender people who have sex with men in the US, Brazil and Peru (HVTN 704/HPTN 085) and HIV-negative cisgender women in sub-Saharan Africa (HVTN 703/HPTN 081).
Getty Images
The start of this year’s HIV Research for Prevention Conference brings with it new findings show the potential of special antibodies to prevent HIV infection
This antibody can make people 75% less likely to become infected with a third of existing strains of HIV
Bhekisisa unpacks the study and breaks down the key concepts
There’s a new player in the HIV prevention field. Newly released results from the 4th HIV Research for Prevention Conference offers fresh insight into how the immune system can prevent HIV infection and serve as a guide for a potential, long-awaited HIV vaccine.
Managing Editor, Journal of the International AIDS Society scidev.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scidev.net Daily Mail and Mail on Sunday newspapers.